Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: AVANTGEN INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-09-16 to 2024-09-15
Current total value of award: $1995852
Description: TOPIC 372:  DEVELOPMENT AND VALIDATION OF NON-MOUSE REAGENTS TO ENABLE PRECLINICAL DEVELOPMENT OF NOVEL THERAPEUTICS